Shares of Hemogenyx Pharmaceuticals Plc (LON:HEMO - Get Free Report) hit a new 52-week low on Tuesday . The stock traded as low as GBX 270 ($3.43) and last traded at GBX 284 ($3.60), with a volume of 63610 shares trading hands. The stock had previously closed at GBX 378 ($4.80).
Hemogenyx Pharmaceuticals Stock Performance
The company has a current ratio of 4.38, a quick ratio of 6.72 and a debt-to-equity ratio of 92.09. The company has a market cap of £4.69 billion, a P/E ratio of -35,000.00 and a beta of 3.14. The company's 50-day moving average price is GBX 17.14 and its two-hundred day moving average price is GBX 6.93.
Hemogenyx Pharmaceuticals Company Profile
(
Get Free Report)
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. It is involved in developing products for bone marrow/hematopoietic stem cell (BM/HSC) transplant market, including CDX bi-specific antibody targeting relapsed/refractory acute myeloid leukaemia (R/R AML); HEMO-CAR-T therapy, a chimeric antigen receptor T-cells to identify and destroy human AML-derived cells in vitro and in vivo; and Human Postnatal Hematopoietic Endothelial Cells, a stem cell therapy product for BM/HSC transplants.
Further Reading
Before you consider Hemogenyx Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hemogenyx Pharmaceuticals wasn't on the list.
While Hemogenyx Pharmaceuticals currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
